Cardiac Safety Services Market

Cardiac Safety Services Market by Type (Standalone, Integrated), Services (ECG/Holter measurement, Blood Pressure, Cardiac Imaging, Thorough QT Study, Other Services), End User (Pharmaceutical & Biopharmaceutical Companies, CRO) - Global Forecast to 2024

Report Code: PH 7455 Nov, 2019, by marketsandmarkets.com

[135 Pages Report] The cardiac safety services market is expected to grow from USD 442 million in 2019 to reach USD 752 million by 2024, at a CAGR of 11.2%. Market growth is largely driven by factors such as the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increased outsourcing of R&D activities, and the increasing number of clinical trials. The introduction of new technologies & methods and growth in the biosimilars and biologics market are expected to provide a wide range of growth opportunities for players operating in this market.

Cardiac Safety Services Market

The integrated services segment to dominate the cardiac safety services market in 2018.

Based on type, the market is categorized into integrated and standalone services. The integrated services segment accounted for the largest market share in 2018. This is primarily attributed to the benefits of bundled services to oversee end-to-end developments, as compared to the specificity of standalone services.

The pharmaceutical & biopharmaceutical companies segment to dominate and grow at the fastest rate in the cardiac safety services market in 2018.

Based on end user, the market is segmented into pharmaceutical & biopharmaceutical companies and contract research organizations (CROs). The pharmaceutical & biopharmaceutical companies segment accounted for the largest market share in 2018. This segment is also poised to be growing at the fastest rate during the forecast period. The large share of this segment can be attributed to factors such as the stringent regulations for drug safety and increasing R&D activities to develop new drugs.

Cardiac Safety Services Market

North America was the largest regional market for cardiac safety services  in 2018

The global market is segmented into North America, Europe, the Asia Pacific, and the RoW. In 2018, North America commanded the largest share of the market. This can be attributed to the presence of major pharmaceutical & biopharmaceutical companies and the large number of clinical trials performed in the region.

Key Market Players

The prominent players operating in this market include Biotrial (France), Banook Group (France & Canada), Bioclinica (a subsidiary of Cinven, US), Certara L.P. (US), Celerion, Inc. (US), ERT, Inc. (US), Laboratory Corporation of America Holdings (US), Medpace Holdings, Inc. (US), Ncardia AG (Belgium), Richmond Pharmacology (UK), PhysioStim (France), Shanghai Medicilon Inc. (China), Pharmaceutical Product Development LLC (US), SGS S.A. (Switzerland), BioTelemetry, Inc. (US), and IQVIA (US).

Laboratory Corporation of America Holdings (US) was one of the leading players in the market in 2018. The company has pursued competitive strategies such as acquisitions and expansions in order to solidify its presence in the markets it operates in. In 2015, LabCorp acquired Covance, a prominent player in the market, thus helping the firm enter this market and expand its presence. This development has significantly helped LabCorp in tapping into new revenue streams and diversifying its economic cycle.

Scope of the Report

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Value (USD)

Segments covered

  • Type of Service, Type, End User, and Region

Geographies covered

North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and RoE), APAC (China, Japan, India, Australia and RoAPAC) and Rest of the World

Companies covered

Major sixteen players covered, including
Biotrial (France), Banook Group (France & Canada), Bioclinica (a subsidiary of Cinven, US), Certara L.P. (US), Celerion, Inc. (US), ERT, Inc. (US), Laboratory Corporation of America Holdings (US), Medpace Holdings, Inc. (US), Ncardia AG (Belgium), Richmond Pharmacology (UK), PhysioStim (France), Shanghai Medicilon Inc. (China), Pharmaceutical Product Development LLC (US), SGS S.A. (Switzerland), BioTelemetry, Inc. (US), and IQVIA (US)

This research report categorizes the market into the following segments and subsegments:

Cardiac Safety Services Market, by Type of Service

  • ECG/Holter Measurement
  • Blood Pressure Measurement
  • Cardiovascular Imaging
  • Thorough QT Studies
  • Other Services

Cardiac Safety Services Market, by Type

  • Integrated Services
  • Standalone Services

Cardiac Safety Services Market, by End User

  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Research Organizations

Cardiac Safety Services Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Rest of the World

Recent Developments

  • In 2018, ERT launched its rapid ECG.
  • In 2018, Bioclinica launched an expanded and enhanced 'SMART' technology suite available with medical imaging, EDC, and IRT.
  • In 2018, ERT launched its Phase I QT Centre of Excellence in France.

Key Questions Addressed by the Report

  • What are the type of cardiac safety services and their respective market shares in the overall market?
  • Where will all these developments take the industry in the mid-to-long term?
  • What are the recent trends affecting the market?
  • Who are the key players in the market and how intense is the competition?

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Market Size Estimation: Bottom-Up Approach
           2.2.2 Market Size Estimation: Top-Down Approach
           2.2.3 Growth Forecast
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 26)

4 Premium Insights (Page No. - 29)
    4.1 Cardiac Safety Services Market Overview
    4.2 North America: Market, By End User & Country (2018)
    4.3 Market: Geographic Growth Opportunities

5 Market Overview (Page No. - 32)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Growing R&D Expenditure in the Pharmaceutical & Biopharmaceutical Industry
                    5.2.1.2 Increased Outsourcing of R&D Activities
                    5.2.1.3 Increasing Number of Clinical Trials
           5.2.2 Opportunities
                    5.2.2.1 Introduction of New Technologies and Methods
                    5.2.2.2 Growth in the Biosimilars and Biologics Markets
           5.2.3 Challenges
                    5.2.3.1 High Cost of Cardiac Safety Evaluation

6 Cardiac Safety Services Market, By Type of Service (Page No. - 37)
    6.1 Introduction
    6.2 ECG/Holter Measurement Services
           6.2.1 ECG/Holter Measurement Services Help in the R&D of Novel Methods for Clinical Trials and Drug Discovery
    6.3 Blood Pressure Measurement Services
           6.3.1 Increasing R&D Activities to Drive the Growth of the Blood Pressure Measurement Services Segment
    6.4 Cardiovascular Imaging Services
           6.4.1 Cardiovascular Imaging Services Help in Drug Evaluation
    6.5 Thorough QT Studies
           6.5.1 Need to Meet Stringent Regulatory Requirements is Driving the Demand for Thorough QT Studies
    6.6 Other Services

7 Cardiac Safety Services Market, By Type (Page No. - 49)
    7.1 Introduction
    7.2 Integrated Services
           7.2.1 Integrated Services Dominate the Market
    7.3 Standalone Services
           7.3.1 Standalone Services Segment Witnessing Growth Due to Cost-Effectiveness

8 Cardiac Safety Services Market, By End User (Page No. - 55)
    8.1 Introduction
    8.2 Pharmaceutical & Biopharmaceutical Companies
           8.2.1 Increasing R&D By Pharmaceutical & Biopharmaceutical Companies to Drive the Demand for Cardiac Safety Services
    8.3 Contract Research Organizations
           8.3.1 Increasing Outsourcing of Drug Discovery Processes to Support the Growth of This End-User Segment

9 Cardiac Safety Services Market, By Region (Page No. - 61)
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 US Dominates the Global Market for Cardiac Safety Services
           9.2.2 Canada
                    9.2.2.1 Canada has High-Quality Clinical Trial Infrastructure and Expertise
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Availability of Skilled Staff and Flexible Labor Laws Have Made Germany A Popular Hub in the Eu for Clinical Trials
           9.3.2 UK
                    9.3.2.1 Steady Growth of Pharmaceutical R&D Expenditure Indicates Favorable Prospects for Cardiac Safety Services
           9.3.3 France
                    9.3.3.1 A Large Number of Cancer Therapy-Focused Clinical Trials are Conducted in France
           9.3.4 Italy
                    9.3.4.1 Italy’s Strong Pharma Industry and Availability of Funding for Drug Development Have Fueled Market Growth
           9.3.5 Spain
                    9.3.5.1 Growing Investment in Pharmaceutical R&D and Favorable Climate for Approvals are Driving Market Growth
           9.3.6 Rest of Europe
    9.4 Asia Pacific
           9.4.1 China
                    9.4.1.1 China Dominates the APAC Market for Cardiac Safety Services
           9.4.2 Japan
                    9.4.2.1 Strong Ip Rights and Supportive Policies Have Strengthened the R&D Sector in Japan
           9.4.3 India
                    9.4.3.1 Lack of Language Barriers and Availability of Trained Resources Make India an Attractive Destination for Clinical Trials
           9.4.4 Australia
                    9.4.4.1 Favorable R&D Tax Incentives and Cash Rebates Have Driven Clinical Trial Activity in Australia
           9.4.5 Rest of Asia Pacific
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 98)
     10.1 Overview
     10.2 Market Player Ranking
     10.3 Competitive Situation and Trends
             10.3.1 Services Launches & Upgrades
             10.3.2 Expansions
             10.3.3 Acquisitions
             10.3.4 Partnerships, Alliances, and Agreements
             10.3.5 Other Strategies
     10.4 Competitive Leadership Mapping – Overall Market (2019)
             10.4.1 Visionary Leaders
             10.4.2 Dynamic Differentiators
             10.4.3 Innovators
             10.4.4 Emerging Companies

11 Company Profiles (Page No. - 105)
(Business Overview, Services Offered, Recent Developments, and MnM View)*
     11.1 Bioclinica (A Subsidiary of Cinven)
     11.2 Labcorp
     11.3 BioTelemetry, Inc.
     11.4 ERT, Inc.
     11.5 Banook Group
     11.6 IQVIA
     11.7 Biotrial
     11.8 Certara, L.P.
     11.9 Celerion, Inc.
     11.10 Medpace
     11.11 Ncardia
     11.12 Richmond Pharmacology
     11.13 PhysioStim
     11.14 Shanghai Medicilon Inc.
     11.15 Pharmaceutical Product Development LLC
     11.16 SGS S.A.

*Details on Business Overview, Services Offered, Recent Developments, and MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 129)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Available Customizations
     12.4 Related Reports
     12.5 Author Details


List of Tables (108 Tables)

Table 1 R&D Expenditure & Percentage Change, By Company
Table 2 Market, By Type of Service, 2017–2024 (USD Million)
Table 3 ECG/Holter Measurement Services Market, By Region, 2017–2024 (USD Million)
Table 4 North America: ECG/Holter Measurement Services Market, By Country, 2017–2024 (USD Million)
Table 5 Europe: ECG/Holter Measurement Services Market, By Country, 2017–2024 (USD Million)
Table 6 Asia Pacific: ECG/Holter Measurement Services Market, By Country, 2017–2024 (USD Million)
Table 7 Blood Pressure Measurement Services Market, By Region, 2017–2024 (USD Million)
Table 8 North America: Blood Pressure Measurement Services Market, By Country, 2017–2024 (USD Million)
Table 9 Europe: Blood Pressure Measurement Services Market, By Country, 2017–2024 (USD Million)
Table 10 Asia Pacific: Blood Pressure Measurement Services Market, By Country, 2017–2024 (USD Million)
Table 11 Cardiovascular Imaging Services Market, By Region, 2017–2024 (USD Million)
Table 12 North America: Cardiovascular Imaging Services Market, By Country, 2017–2024 (USD Million)
Table 13 Europe: Cardiovascular Imaging Services Market, By Country, 2017–2024 (USD Million)
Table 14 Asia Pacific: Cardiovascular Imaging Services Market, By Country, 2017–2024 (USD Million)
Table 15 Thorough QT Studies Market, By Region, 2017–2024 (USD Million)
Table 16 North America: Thorough QT Studies Market, By Country, 2017–2024 (USD Million)
Table 17 Europe: Thorough QT Studies Market, By Country, 2017–2024 (USD Million)
Table 18 Asia Pacific: Thorough QT Studies Market, By Country, 2017–2024 (USD Million)
Table 19 Other Cardiac Safety Services Market, By Region, 2017–2024 (USD Million)
Table 20 North America: Other Market, By Country, 2017–2024 (USD Million)
Table 21 Europe: Other Market, By Country, 2017–2024 (USD Million)
Table 22 Asia Pacific: Other Market, By Country, 2017–2024 (USD Million)
Table 23 Market, By Type, 2017–2024 (USD Million)
Table 24 Integrated Market, By Region, 2017–2024 (USD Million)
Table 25 North America: Integrated Cardiac Safety Services Market, By Country, 2017–2024 (USD Million)
Table 26 Europe: Integrated Market, By Country, 2017–2024 (USD Million)
Table 27 Asia Pacific: Integrated Market, By Country, 2017–2024 (USD Million)
Table 28 Standalone Market, By Region, 2017–2024 (USD Million)
Table 29 North America: Standalone Market, By Country, 2017–2024 (USD Million)
Table 30 Europe: Standalone Market, By Country, 2017–2024 (USD Million)
Table 31 Asia Pacific: Standalone Market, By Country, 2017–2024 (USD Million)
Table 32 Cardiac Safety Services Market, By End User, 2017–2024 (USD Million)
Table 33 Market for Pharmaceutical & Biopharmaceutical Companies, By Region, 2017–2024 (USD Million)
Table 34 North America: Cardiac Safety Services Market for Pharmaceutical & Biopharmaceutical Companies, By Country, 2017–2024 (USD Million)
Table 35 Europe: Market for Pharmaceutical & Biopharmaceutical Companies, By Country, 2017–2024 (USD Million)
Table 36 Asia Pacific: Market for Pharmaceutical & Biopharmaceutical Companies, By Country, 2017–2024 (USD Million)
Table 37 Market for Contract Research Organizations, By Region, 2017–2024 (USD Million)
Table 38 North America: Cardiac Safety Services Market for Contract Research Organizations, By Country, 2017–2024 (USD Million)
Table 39 Europe: Market for Contract Research Organizations, By Country, 2017–2024 (USD Million)
Table 40 Asia Pacific: Market for Contract Research Organizations, By Country, 2017–2024 (USD Million)
Table 41 Market, By Region, 2017–2024 (USD Million)
Table 42 North America: Market, By Country, 2017–2024 (USD Million)
Table 43 North America: Market, By Type of Service, 2017–2024 (USD Million)
Table 44 North America: Cardiac Safety Services Market, By Type, 2017–2024 (USD Million)
Table 45 North America: Market, By End User, 2017–2024 (USD Million)
Table 46 Total Number of Clinical Trials in the US (Till October 2019)
Table 47 Number of Clinical Trials Started in the Us, By Company, 2017
Table 48 US: Market, By Type of Service, 2017–2024 (USD Million)
Table 49 US: Cardiac Safety Services Market, By Type, 2017–2024 (USD Million)
Table 50 US: Market, By End User, 2017–2024 (USD Million)
Table 51 Number of Active Clinical Trials in Canada, By Condition (2019)
Table 52 Number of Active Clinical Trials in Canada, By Company, 2017
Table 53 Canada: Market, By Type of Service, 2017–2024 (USD Million)
Table 54 Canada: Market, By Type, 2017–2024 (USD Million)
Table 55 Canada: Market, By End User, 2017–2024 (USD Million)
Table 56 Europe: Market, By Country, 2017–2024 (USD Million)
Table 57 Europe: Cardiac Safety Services Market, By Type of Service, 2017–2024 (USD Million)
Table 58 Europe: Market, By Type, 2017–2024 (USD Million)
Table 59 Europe: Market, By End User, 2017–2024 (USD Million)
Table 60 Germany: Market, By Type of Service, 2017–2024 (USD Million)
Table 61 Germany: Market, By Type, 2017–2024 (USD Million)
Table 62 Germany: Table 63 UK: Market, By Type of Service, 2017–2024 (USD Million)
Table 64 UK: Market, By Type, 2017–2024 (USD Million)
Table 65 UK: Market, By End User, 2017–2024 (USD Million)
Table 66 Number of Clinical Trials Started in France, By Company, 2017
Table 67 France: Market, By Type of Service, 2017–2024 (USD Million)
Table 68 France: Market, By Type, 2017–2024 (USD Million)
Table 69 France: Market, By End User, 2017–2024 (USD Million)
Table 70 Number of Clinical Trials Started in Italy, By Company, 2017
Table 71 Italy: Market, By Type of Service, 2017–2024 (USD Million)
Table 72 Italy: Market, By Type, 2017–2024 (USD Million)
Table 73 Italy: Market, By End User, 2017–2024 (USD Million)
Table 74 Spain: Market, By Type of Service, 2017–2024 (USD Million)
Table 75 Spain: Market, By Type, 2017–2024 (USD Million)
Table 76 Spain: Market, By End User, 2017–2024 (USD Million)
Table 77 RoE: Market, By Type of Service, 2017–2024 (USD Million)
Table 78 RoE: Market, By Type, 2017–2024 (USD Million)
Table 79 RoE: Market, By End User, 2017–2024 (USD Million)
Table 80 Clinical Trials in the Asia Pacific, By Therapeutic Area, 2017
Table 81 APAC: Market, By Country, 2017–2024 (USD Million)
Table 82 APAC: Market, By Type of Service, 2017–2024 (USD Million)
Table 83 APAC: Cardiac Safety Services Market, By Type, 2017–2024 (USD Million)
Table 84 APAC: Market, By End User, 2017–2024 (USD Million)
Table 85 China: Market, By Type of Service, 2017–2024 (USD Million)
Table 86 China: Market, By Type, 2017–2024 (USD Million)
Table 87 China: Market, By End User, 2017–2024 (USD Million)
Table 88 Japan: Market, By Type of Service, 2017–2024 (USD Million)
Table 89 Japan: Market, By Type, 2017–2024 (USD Million)
Table 90 Japan: Market, By End User, 2017–2024 (USD Million)
Table 91 India: Market, By Type of Service, 2017–2024 (USD Million)
Table 92 India: Cardiac Safety Services Market, By Type, 2017–2024 (USD Million)
Table 93 India: Market, By End User, 2017–2024 (USD Million)
Table 94 Australia: Market, By Type of Service, 2017–2024 (USD Million)
Table 95 Australia: Market, By Type, 2017–2024 (USD Million)
Table 96 Australia: Market, By End User, 2017–2024 (USD Million)
Table 97 RoAPAC: Market, By Type of Service, 2017–2024 (USD Million)
Table 98 RoAPAC: Market, By Type, 2017–2024 (USD Million)
Table 99 RoAPAC: Market, By End User, 2017–2024 (USD Million)
Table 100 RoW: Market, By Type of Service, 2017–2024 (USD Million)
Table 101 RoW: Market, By Type, 2017–2024 (USD Million)
Table 102 RoW: Market, By End User, 2017–2024 (USD Million)
Table 103 Global Cardiac Safety Services Market Player Ranking, 2018
Table 104 Service Launches & Upgrades, 2016–2019
Table 105 Expansions, 2016–2019
Table 106 Acquisitions, 2016–2019
Table 107 Partnerships, Alliances, and Agreements, 2016–2019
Table 108 Other Strategies, 2016– 2019
 
 
List of Figures (32 Figures)
 
Figure 1 Cardiac Safety Services Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market, By Type of Service, 2019 Vs. 2024 (USD Million)
Figure 8 Market, By Type, 2019 Vs. 2024 (USD Million)
Figure 9 Market, By End User, 2019 Vs. 2024 (USD Million)
Figure 10 Market, By Region, 2019 Vs. 2024 (USD Million)
Figure 11 Increasing R&D Expenditure in the Pharmaceutical & Biotechnology Industry to Drive Market Growth
Figure 12 Pharmaceutical & Biopharmaceutical Companies Were the Largest End Users of Cardiac Safety Services in the North American Market in 2018
Figure 13 The US to Register the Highest Growth in the Cardiac Safety Services Market During the Forecast Period
Figure 14 Market: Drivers, Opportunities, and Challenges
Figure 15 Active Pharmaceutical Pipeline, January 2009 to January 2019
Figure 16 Total Number of Registered Studies (2005–2017)
Figure 17 Trial Count By Phase & Therapeutic Area, 2017
Figure 18 R&D Spending of Phrma Member Companies (USD Billion)
Figure 19 Total Number of Clinical Trials: Global Vs. North America (October 2019)
Figure 20 North America: Market Snapshot
Figure 21 UK: Pharmaceutical R&D Expenditure, 2013–2017
Figure 22 Spain: Pharmaceutical R&D Expenditure, 2011–2017
Figure 23 Clinical Trial Penetration: Developed Vs. Developing Countries, 2016
Figure 24 Asia Pacific: Market Snapshot
Figure 25 Service Launch and Upgradation—Key Growth Strategies Adopted By Market Players From 2016 to 2019
Figure 26 Competitive Leadership Mapping of the Cardiac Safety Services Market
Figure 27 Labcorp: Company Snapshot
Figure 28 BioTelemetry: Company Snapshot
Figure 29 IQVIA: Company Snapshot
Figure 30 MeDPAce: Company Snapshot
Figure 31 Ncardia: Company Snapshot
Figure 32 SGS S.A.: Company Snapshot

The study involved four major activities in estimating the current market size of the cardiac safety services market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary sources referred to for this research study include publications from government sources such as white papers; articles from recognized authors; gold standard and silver standard websites, directories, and databases; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations were referred to identify and collect information for this study.

Primary Research

The cardiac safety services market comprises several stakeholders, such as cardiac safety service providers, vendors, and distributors. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Following is a breakdown of primary respondents:

Cardiac Safety Services Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the cardiac safety services industry.

Report Objectives

  • To define, describe, segment, and forecast the global cardiac safety services market based on the type of service, type, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of a competitive landscape for major players operating in the market
  • To forecast the size of market segments with respect to four major regions, namely, North America, Europe, the Asia Pacific (APAC), and the Rest of the World (RoW)
  • To profile key market players and comprehensively analyze their service portfolios, market positions, and core competencies
  • To track and analyze competitive developments in the market, such as partnerships & agreements, expansions & joint ventures, mergers & acquisitions, service launches, and R&D activities.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
  • Further Split of the Market for the Rest of the World
  • Market size and growth rate estimates for LATAM, the Middle East, and Africa
COVID-19

Get in-depth analysis of the COVID-19 impact on the Cardiac Safety Services Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Cardiac Safety Services Market

Request For Special Pricing
Report Code
PH 7455
Published ON
Nov, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cardiac Safety Services Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home